Filing Details
- Accession Number:
- 0000899243-16-015340
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-04 21:00:20
- Reporting Period:
- 2016-03-04
- Filing Date:
- 2016-03-04
- Accepted Time:
- 2016-03-04 21:00:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1594864 | Juno Therapeutics Inc. | JUNO | Biological Products, (No Disgnostic Substances) (2836) | 463656275 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1627387 | Steve Harr | C/O 307 Westlake Avenue North, Suite 300 Seattle WA 98109 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-03-04 | 5,000 | $45.00 | 730,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2014, as amended March 24, 2015.